A new guideline for the management of patients with ventricular arrhythmias and the
prevention of sudden cardiac death has been published by the European Society of …

Electrical storm is present when a cluster of ventricular arrhythmias (VAs) occurs within a
short time frame. The most widely accepted definition is 3 or more episodes of VA within a …

Ventricular tachycardia (VT) is a potentially fatal cardiac rhythm disorder. Implantable
cardioverter defibrillators (ICDs) are the primary management strategy for VT and have been …

Lidocaine is classified as a class Ib anti‐arrhythmic that blocks voltage‐and pH‐dependent
sodium channels. It exhibits well investigated anti‐arrhythmic effects and has been the anti …

Background The effects of amiodarone and lidocaine on the return of spontaneous
circulation (ROSC) in relation to time to treatment in patients with out‐of‐hospital cardiac …

Background Implantable cardioverter-defibrillator (ICD) shocks are associated with higher
rates of mortality and reduced quality of life. In this study we aimed to investigate the …

Aims Catheter ablation is superior to escalated antiarrhythmic drugs among patients with
ventricular tachycardia (VT) and prior myocardial infarction (MI). However, it is uncertain …

Despite impressive developments in the field of ventricular arrhythmias, there is still a
relevant number of patients with ventricular arrhythmias who require antiarrhythmic drug …

Sarcoidosis is a multisystem granulomatous disease with 2 different phases (inflammation
and scar). In the current era of targeted use of implantable cardioverter-defibrillators and …

Background Catheter ablation improves ventricular tachycardia (VT) event-free (time to
event) survival in patients with antiarrhythmic drug (AAD)-refractory VT and previous …